Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum

Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the lack of ideal vaccines or drugs. Recent advances in immunoinformatics and bioinformatics could be a promising approach in designing a new recombinant v...

Full description

Saved in:
Bibliographic Details
Published in:International journal of peptide research and therapeutics 2020-09, Vol.26 (3), p.1417-1428
Main Authors: Hashemzadeh, Pejman, Ghorbanzadeh, Vajihe, Lashgarian, Hamed Esmaeil, Kheirandish, Farnaz, Dariushnejad, Hassan
Format: Article
Language:English
Subjects:
Adjuvants
Amino acid composition
Animal Anatomy
Antigens
Biochemistry
Bioinformatics
Biomedical and Life Sciences
Computer applications
Epitopes
Histology
Homology
Hsp70 protein
Immune system
Immunodominance
Immunogenicity
Immunosuppressive agents
Leishmania infantum
Life Sciences
Major histocompatibility complex
Molecular Medicine
Morphology
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
Protein interaction
Protozoa
Tuberculosis
Vaccines
Visceral leishmaniasis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3
cites cdi_FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3
container_end_page 1428
container_issue 3
container_start_page 1417
container_title International journal of peptide research and therapeutics
container_volume 26
creator Hashemzadeh, Pejman
Ghorbanzadeh, Vajihe
Lashgarian, Hamed Esmaeil
Kheirandish, Farnaz
Dariushnejad, Hassan
description Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the lack of ideal vaccines or drugs. Recent advances in immunoinformatics and bioinformatics could be a promising approach in designing a new recombinant vaccine for VL treatment. In this study, a new recombinant vaccine against Leishmania infantum ( L. infantum ) designed by the computational method and Gp63, Hsp70 and Kmp11 antigens from L. infantum were selected as potential immunodominant epitopes. RpfE and RpfB from Mycobacterium tuberculosis used as adjuvants for enhancing vaccine immunogenicity. bioinformatic tools were used to analyze different aspects of the designed vaccine including, protein–protein interactions, B cell epitopes, MHC class I and II epitopes, the amino acid composition of multi-epitope vaccine, immunogenic behavior, and 3D homology modeling. This study revealed that our designed recombinant vaccine is able to induce responses of the immune system against L. infantum , and may be helpful to control VL infection, after appropriate in vitro and in vivo immunological assays.
doi_str_mv 10.1007/s10989-019-09949-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2428281538</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2428281538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3</originalsourceid><addsrcrecordid>eNp9kEtPAyEUhYnRxFr9A65IXI8Cw8zAstZHTaoufGwJQ2FK04ERGBP_vWg17lzcx-Kcc3M_AE4xOscINRcRI854gXAuzikv6j0wwVVTFiVHdP93x5QfgqMYNwhVpMFoAvqFDE7HaF0HL623zvjQy2QVnA1D8FKtdYTJwysdbefgg3_XW3g_bpMt9GCTHzR8GtvR2QRfpVLWaTjrpHUxwaW2cd1LZyXMsdKlsT8GB0Zuoz75mVPwcnP9PF8Uy8fbu_lsWagS81Qws6r4isoWKbLikrd12xLalAwxZlTuDTWoZZrWmCDTcKYIxZLUknGtODPlFJztcvMLb6OOSWz8GFw-KQgljDBclSyryE6lgo8xaCOGYHsZPgRG4gur2GEVGav4xirqbCp3ppjFrtPhL_of1yeG7nxE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2428281538</pqid></control><display><type>article</type><title>Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum</title><source>Springer Link</source><creator>Hashemzadeh, Pejman ; Ghorbanzadeh, Vajihe ; Lashgarian, Hamed Esmaeil ; Kheirandish, Farnaz ; Dariushnejad, Hassan</creator><creatorcontrib>Hashemzadeh, Pejman ; Ghorbanzadeh, Vajihe ; Lashgarian, Hamed Esmaeil ; Kheirandish, Farnaz ; Dariushnejad, Hassan</creatorcontrib><description>Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the lack of ideal vaccines or drugs. Recent advances in immunoinformatics and bioinformatics could be a promising approach in designing a new recombinant vaccine for VL treatment. In this study, a new recombinant vaccine against Leishmania infantum ( L. infantum ) designed by the computational method and Gp63, Hsp70 and Kmp11 antigens from L. infantum were selected as potential immunodominant epitopes. RpfE and RpfB from Mycobacterium tuberculosis used as adjuvants for enhancing vaccine immunogenicity. bioinformatic tools were used to analyze different aspects of the designed vaccine including, protein–protein interactions, B cell epitopes, MHC class I and II epitopes, the amino acid composition of multi-epitope vaccine, immunogenic behavior, and 3D homology modeling. This study revealed that our designed recombinant vaccine is able to induce responses of the immune system against L. infantum , and may be helpful to control VL infection, after appropriate in vitro and in vivo immunological assays.</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-019-09949-6</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Adjuvants ; Amino acid composition ; Animal Anatomy ; Antigens ; Biochemistry ; Bioinformatics ; Biomedical and Life Sciences ; Computer applications ; Epitopes ; Histology ; Homology ; Hsp70 protein ; Immune system ; Immunodominance ; Immunogenicity ; Immunosuppressive agents ; Leishmania infantum ; Life Sciences ; Major histocompatibility complex ; Molecular Medicine ; Morphology ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Polymer Sciences ; Protein interaction ; Protozoa ; Tuberculosis ; Vaccines ; Visceral leishmaniasis</subject><ispartof>International journal of peptide research and therapeutics, 2020-09, Vol.26 (3), p.1417-1428</ispartof><rights>Springer Nature B.V. 2019</rights><rights>Springer Nature B.V. 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3</citedby><cites>FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3</cites><orcidid>0000-0003-2499-5631 ; 0000-0001-8039-9792 ; 0000-0002-4195-3516 ; 0000-0003-2680-0703 ; 0000-0003-2477-9461</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hashemzadeh, Pejman</creatorcontrib><creatorcontrib>Ghorbanzadeh, Vajihe</creatorcontrib><creatorcontrib>Lashgarian, Hamed Esmaeil</creatorcontrib><creatorcontrib>Kheirandish, Farnaz</creatorcontrib><creatorcontrib>Dariushnejad, Hassan</creatorcontrib><title>Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the lack of ideal vaccines or drugs. Recent advances in immunoinformatics and bioinformatics could be a promising approach in designing a new recombinant vaccine for VL treatment. In this study, a new recombinant vaccine against Leishmania infantum ( L. infantum ) designed by the computational method and Gp63, Hsp70 and Kmp11 antigens from L. infantum were selected as potential immunodominant epitopes. RpfE and RpfB from Mycobacterium tuberculosis used as adjuvants for enhancing vaccine immunogenicity. bioinformatic tools were used to analyze different aspects of the designed vaccine including, protein–protein interactions, B cell epitopes, MHC class I and II epitopes, the amino acid composition of multi-epitope vaccine, immunogenic behavior, and 3D homology modeling. This study revealed that our designed recombinant vaccine is able to induce responses of the immune system against L. infantum , and may be helpful to control VL infection, after appropriate in vitro and in vivo immunological assays.</description><subject>Adjuvants</subject><subject>Amino acid composition</subject><subject>Animal Anatomy</subject><subject>Antigens</subject><subject>Biochemistry</subject><subject>Bioinformatics</subject><subject>Biomedical and Life Sciences</subject><subject>Computer applications</subject><subject>Epitopes</subject><subject>Histology</subject><subject>Homology</subject><subject>Hsp70 protein</subject><subject>Immune system</subject><subject>Immunodominance</subject><subject>Immunogenicity</subject><subject>Immunosuppressive agents</subject><subject>Leishmania infantum</subject><subject>Life Sciences</subject><subject>Major histocompatibility complex</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Polymer Sciences</subject><subject>Protein interaction</subject><subject>Protozoa</subject><subject>Tuberculosis</subject><subject>Vaccines</subject><subject>Visceral leishmaniasis</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPAyEUhYnRxFr9A65IXI8Cw8zAstZHTaoufGwJQ2FK04ERGBP_vWg17lzcx-Kcc3M_AE4xOscINRcRI854gXAuzikv6j0wwVVTFiVHdP93x5QfgqMYNwhVpMFoAvqFDE7HaF0HL623zvjQy2QVnA1D8FKtdYTJwysdbefgg3_XW3g_bpMt9GCTHzR8GtvR2QRfpVLWaTjrpHUxwaW2cd1LZyXMsdKlsT8GB0Zuoz75mVPwcnP9PF8Uy8fbu_lsWagS81Qws6r4isoWKbLikrd12xLalAwxZlTuDTWoZZrWmCDTcKYIxZLUknGtODPlFJztcvMLb6OOSWz8GFw-KQgljDBclSyryE6lgo8xaCOGYHsZPgRG4gur2GEVGav4xirqbCp3ppjFrtPhL_of1yeG7nxE</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Hashemzadeh, Pejman</creator><creator>Ghorbanzadeh, Vajihe</creator><creator>Lashgarian, Hamed Esmaeil</creator><creator>Kheirandish, Farnaz</creator><creator>Dariushnejad, Hassan</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0003-2499-5631</orcidid><orcidid>https://orcid.org/0000-0001-8039-9792</orcidid><orcidid>https://orcid.org/0000-0002-4195-3516</orcidid><orcidid>https://orcid.org/0000-0003-2680-0703</orcidid><orcidid>https://orcid.org/0000-0003-2477-9461</orcidid></search><sort><creationdate>20200901</creationdate><title>Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum</title><author>Hashemzadeh, Pejman ; Ghorbanzadeh, Vajihe ; Lashgarian, Hamed Esmaeil ; Kheirandish, Farnaz ; Dariushnejad, Hassan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adjuvants</topic><topic>Amino acid composition</topic><topic>Animal Anatomy</topic><topic>Antigens</topic><topic>Biochemistry</topic><topic>Bioinformatics</topic><topic>Biomedical and Life Sciences</topic><topic>Computer applications</topic><topic>Epitopes</topic><topic>Histology</topic><topic>Homology</topic><topic>Hsp70 protein</topic><topic>Immune system</topic><topic>Immunodominance</topic><topic>Immunogenicity</topic><topic>Immunosuppressive agents</topic><topic>Leishmania infantum</topic><topic>Life Sciences</topic><topic>Major histocompatibility complex</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Polymer Sciences</topic><topic>Protein interaction</topic><topic>Protozoa</topic><topic>Tuberculosis</topic><topic>Vaccines</topic><topic>Visceral leishmaniasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashemzadeh, Pejman</creatorcontrib><creatorcontrib>Ghorbanzadeh, Vajihe</creatorcontrib><creatorcontrib>Lashgarian, Hamed Esmaeil</creatorcontrib><creatorcontrib>Kheirandish, Farnaz</creatorcontrib><creatorcontrib>Dariushnejad, Hassan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashemzadeh, Pejman</au><au>Ghorbanzadeh, Vajihe</au><au>Lashgarian, Hamed Esmaeil</au><au>Kheirandish, Farnaz</au><au>Dariushnejad, Hassan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2020-09-01</date><risdate>2020</risdate><volume>26</volume><issue>3</issue><spage>1417</spage><epage>1428</epage><pages>1417-1428</pages><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Kala-azar or visceral leishmaniasis (VL) is the most important vector-borne protozoan disease and a life-threatening problem in the globe due to the lack of ideal vaccines or drugs. Recent advances in immunoinformatics and bioinformatics could be a promising approach in designing a new recombinant vaccine for VL treatment. In this study, a new recombinant vaccine against Leishmania infantum ( L. infantum ) designed by the computational method and Gp63, Hsp70 and Kmp11 antigens from L. infantum were selected as potential immunodominant epitopes. RpfE and RpfB from Mycobacterium tuberculosis used as adjuvants for enhancing vaccine immunogenicity. bioinformatic tools were used to analyze different aspects of the designed vaccine including, protein–protein interactions, B cell epitopes, MHC class I and II epitopes, the amino acid composition of multi-epitope vaccine, immunogenic behavior, and 3D homology modeling. This study revealed that our designed recombinant vaccine is able to induce responses of the immune system against L. infantum , and may be helpful to control VL infection, after appropriate in vitro and in vivo immunological assays.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-019-09949-6</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-2499-5631</orcidid><orcidid>https://orcid.org/0000-0001-8039-9792</orcidid><orcidid>https://orcid.org/0000-0002-4195-3516</orcidid><orcidid>https://orcid.org/0000-0003-2680-0703</orcidid><orcidid>https://orcid.org/0000-0003-2477-9461</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1573-3149
ispartof International journal of peptide research and therapeutics, 2020-09, Vol.26 (3), p.1417-1428
issn 1573-3149
1573-3904
language eng
recordid cdi_proquest_journals_2428281538
source Springer Link
subjects Adjuvants
Amino acid composition
Animal Anatomy
Antigens
Biochemistry
Bioinformatics
Biomedical and Life Sciences
Computer applications
Epitopes
Histology
Homology
Hsp70 protein
Immune system
Immunodominance
Immunogenicity
Immunosuppressive agents
Leishmania infantum
Life Sciences
Major histocompatibility complex
Molecular Medicine
Morphology
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
Protein interaction
Protozoa
Tuberculosis
Vaccines
Visceral leishmaniasis
title Harnessing Bioinformatic Approaches to Design Novel Multi-epitope Subunit Vaccine Against Leishmania infantum
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A39%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Harnessing%20Bioinformatic%20Approaches%20to%20Design%20Novel%20Multi-epitope%20Subunit%20Vaccine%20Against%20Leishmania%20infantum&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Hashemzadeh,%20Pejman&rft.date=2020-09-01&rft.volume=26&rft.issue=3&rft.spage=1417&rft.epage=1428&rft.pages=1417-1428&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-019-09949-6&rft_dat=%3Cproquest_cross%3E2428281538%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c319t-8fd59d4ab0c2d9a9b6bb24738088fc80874f0b8e46120f798c241a26a89ec98f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2428281538&rft_id=info:pmid/&rfr_iscdi=true